Organic & Biomolecular Chemistry · 2007 · 60 citations · 27 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryStructure-activity RelationshipsHeterocyclic ChemistryLigand BindingPotency OptimizationReceptor PharmacologyStructure-activity Relationship AnalysisLeukotriene PharmacologyLeukotriene Receptor PharmacologyMedicinal Chemistry ApplicationsMedicinal HeterocyclesReceptor Binding Optimization
Several 2-alkylcarbamoyl-1-alkylvinylbenzo[b]furans were designed to find a selective leukotriene B4 (LTB4) receptor antagonist. 2-(2-Alkylcarbamoyl-1-alkylvinyl)benzo[b]furans having a substituent group at the 3-position, 4-(2-alkylcarbamoyl-1-methylvinyl)benzo[b]furans having a substituent group at the 3-position, and 7-(2-alkylcarbamoyl-1-methylvinyl)benzo[b]furans and 3-(2-alkylcarbamoyl-1-alkylvinyl)benzo[b]furans were prepared and evaluated for LTB4 receptor (BLT1 and BLT2) inhibitory activities. (E)-3-Amino-4-[2-[2-(3,4-dimethoxyphenyl)ethylcarbamoyl]-1-methylvinyl]benzo[b]furan ((E)-17c) showed potent and selective inhibitory activity for BLT2. On the other hand, (E)-7-(2-diethylcarbamoyl-1-methylvinyl)benzo[b]furan ((E)-27a) showed potent inhibitory activity for both BLT1 and BLT2.
27
A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis
Takehiko Yokomizo, Takashi Izumi, Kyungho Chang et al. · Nature · 1997 · 981 citations · Full text
A Second Leukotriene B4 Receptor, Blt2
Takehiko Yokomizo, Kazuhiko Kato, Kan Terawaki et al. · The Journal of Experimental Medicine · 2000 · 534 citations · Full text